[Skip to content]

tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load
Monday 27 September 2021
Salford GP Header Montage
Latest News:
RSS icon
Medicine, tablets, pills


This is an electronic version of our Formulary written in conjunction with the Medicine Management Committee and the Pharmacy department.   The purpose of the Formulary is:

  • To promote safe, rational and cost effective prescribing within the Trust.
  • To help select the most appropriate drug amongst the many available.


This formulary is intended to act as a rapid reference source.  It is intended for the guidance of medical practitioners, nurses and other healthcare workers.


For local GPs and Non-medical prescribers working in the community there is the Greater Manchester Joint Formulary produced by the Greater Manchester Medicines Management Group (GMMMG).  The formulary ensures that patients receive seamless care across the primary-secondary care interface and reduces the need for switching programmes. All medicines recommended for use in the NHS in a NICE Technology Assessment (TA) are approved for use in Greater Manchester, the GMMMG site provides a list of medicines with a positive recommendation from  NICE and provides links to these TAs in the GMMMG formulary.  In the SRFT formulary below all the drugs with a positive NICE TA that are applicable to SRFT are included in the formulary.


How to use

All medicines are listed alphabetically using the generic name where possible.  Some brand names are used.


  1. Type the drug name in the 'Keywords' box

  2. Click on the 'Search' button

  3. Within the results, click on the 'generic name' of the medicine you are looking for.

  4. Click on the 'Link' - this will take you to further information that talks about that medicine. 



Drug NameBNF CategoryComment / Usage RestrictionsDetails
VoractivSee online BNFApproved April 2016 as per licensed indication for treatment of Mycobacterium Tuberculosis via ICU consultants.   
Valproic Acid - 'Semisodium Valproate'4.2.3 Antimanic drugsNeuropsychiatry and neurorehabilitation for the treatment of manic episodes associated with bipolar disorder 
Valsartan2.5.5.2 Angiotensin-II receptor antagonistsPost-myocardial infarction in clinically stable patients with signs, symptoms or radiological evidence of left ventricular failure and/or with left ventricular systolic dysfunction 
Vancomycin5.1.7 Some other antibacterials  
Varenicline4.10.2 Nicotine dependenceAvailable as an option for smokers who want to stop, as part of a smoking cessation programme - in line with NICE and GMMMG formulary guidance. Anticipated most use will be in the community. 
Vasopressin6.5.2 Posterior pituitary hormones and antagonistsGastroenterology only 
Vecuronium15.1.5 Muscle relaxantsAnaesthetics and ICU directorate only 
VedolizumabSee online BNFModerately to Severe Ulcerative Colitis (TA342) & moderately to severe Chrohn’s disease (TA352) Approved October 2015 as per above TA's  
Velphoro 500mg chewable tabletsSee online BNFFor use as a phosphate binder for renal patients who are likely to be non-adherent with sevelamer due to its high tablet burden, or for those patients who cannot tolerate lanthanum.  Approved March 2016 as per proposed indication.  To be funded by the renal directorate (not included in the dialysis tariff).    
Venlafaxine4.3.4 Other antidepressant drugsFor use in accordance with Acute Stroke Protocols and the Palliative Care Pain and Symptom Control Guidelines 


All material in this section is aimed at health professionals, but is information currently held within the public domain.   Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or contact NHS Direct on 0845 46 47.